Penn Capital Management Company, LLC Ironwood Pharmaceuticals Inc Transaction History

Penn Capital Management Company, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 19, 2019	SELL	$7.8 - $16.13 $5.96 Million - $12.3 Million	-764,028 Closed	0 $0
Q3 2018 Nov 19, 2018	SELL	$14.31 - $17.65 $70,948 - $87,508	-4,958 Reduced 0.64%	764,028 $17.5 Million
Q3 2018 Nov 14, 2018	SELL	$14.31 - $17.65 $1.89 Million - $2.33 Million	-131,870 Reduced 14.64%	768,986 $17.6 Million
Q2 2018 Jul 25, 2018	BUY	$11.83 - $16.2 $609,919 - $835,223	51,557 Added 6.07%	900,856 $17.4 Million
Q1 2018 May 11, 2018	SELL	$11.13 - $13.63 $94,026 - $115,146	-8,448 Reduced 0.98%	849,299 $13.2 Million
Q4 2017 Feb 09, 2018	SELL	$12.16 - $14.58 $309,715 - $371,352	-25,470 Reduced 2.88%	857,747 $13 Million
Q3 2017 Nov 14, 2017	BUY	$12.07 - $14.87 $10.7 Million - $13.1 Million	883,217	883,217 $14.1 Million

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $527M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Penn Capital Management Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Penn Capital Management Company, LLC with notifications on news.